Clinical guidelines for the management of patients with paroxysmal nocturnal hemoglobinuria
Authors:
- V. G. SavchenkoVSV. G. Savchenko
- E. A. LukinaELE. A. Lukina
- E. A. MikhaylovaEME. A. Mikhaylova
- N. V. TsvetaevaNTN. V. Tsvetaeva
- V. D. LatyshevVLV. D. Latyshev
- K. A. LukinaKLK. A. Lukina
- Z. T. FidarovaZFZ. T. Fidarova
- I. V. GaltsevaIGI. V. Galtseva
- V. V. PtushkinVPV. V. Ptushkin
- B. V. AfanasyevBAB. V. Afanasyev
- A. D. KulaginAKA. D. Kulagin
Open Access
- 23 October 2022
- journal article
- research article
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 67 (3) , 426-439-439
Abstract
Introduction. Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired clonal disease of the blood system characterized by intravascular hemolysis, bone marrow dysfunction and an increased risk of thrombotic and organ complications.Aim — to provide relevant clinical recommendations for the provision of medical care to adults and children with PNH.Basic information. Experts from the National Hematological Society association which is focused on the promotion of hematology, transfusiology and bone marrow transplantation along with experts from the public organization, National Society of Pediatric Hematologists and Oncologists, have developed current clinical recommendations for providing medical care to adults and children with PNH. The recommendations address in detail the issues of etiology, pathogenesis, epidemiology, and clinical manifestations of the disease. Special attention is paid to the diagnosis, differential diagnosis, and treatment of PNH based on the principles of evidence.Keywords
This publication has 50 references indexed in Scilit:
- Overview of Complement Activation and RegulationSeminars in Nephrology, 2013
- Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuriaHaematologica, 2012
- Stem cell transplantation for paroxysmal nocturnal hemoglobinuriaHaematologica, 2010
- Long‐term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuriaAmerican Journal of Hematology, 2010
- Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometryCytometry Part B: Clinical Cytometry, 2010
- The Management of Paroxysmal Nocturnal Hemoglobinuria: Recent Advances in Diagnosis and Treatment and New Hope for PatientsSeminars in Hematology, 2009
- The Pathophysiology of Disease in Patients with Paroxysmal Nocturnal HemoglobinuriaHematology-American Society Hematology Education Program, 2008
- CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b‐8 as well as C5b‐9The Journal of Physiology, 2002
- Structure/function studies of human decay‐accelerating factorImmunology, 2000
- Paroxysmal nocturnal hemoglobinuria and the transfusion of washed red cells. A myth revisitedTransfusion, 1989